637 results on '"Denny, Lynette"'
Search Results
2. Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa
3. No woman left behind: achieving cervical cancer elimination among women living with HIV
4. Cancer in sub-Saharan Africa: a Lancet Oncology Commission
5. Cancers of the Vagina and Vulva
6. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer
7. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study
8. Comprehensive Control of Human Papillomavirus Infections and Related Diseases
9. Expanding Prevention of Cervical Cancer in Low- and Middle-Income Countries
10. List of Contributors
11. Cancer screening and prevention in gynaecology
12. Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa
13. Preventing Human Immunodeficiency Virus Infection Among Sexual Assault Survivors in Cape Town, South Africa: An Observational Study
14. Rape and HIV Post-Exposure Prophylaxis: Addressing the Dual Epidemics in South Africa
15. The time is now to implement HPV testing for primary screening in low resource settings
16. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries
17. Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women
18. Abstract IA042: Global disparities: A global approach to understanding the generative mechanisms underpinning cancer health disparities
19. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
20. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer
21. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
22. Cancer of the cervix: Early detection and cost-effective solutions
23. EP349/#554 Logistics of time required to implement a screen-and-treat strategy using point-of-care HPV testing for the prevention of cervical cancer
24. Assessment of the implementation context in preparation for a clinical study of machine-learning algorithms to automate the classification of digital cervical images for cervical cancer screening in resource-constrained settings
25. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022
26. Epidemiology and Burden of Disease Associated with HPV Infection
27. Sexual and reproductive health and HIV services: Integrating HIV/AIDS and cervical cancer prevention and control
28. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer
29. Treatment of cancer in sub-Saharan Africa
30. South African Sexual Assault Survivors' Experiences of Post-Exposure Prophylaxis and Individualized Nursing Care: A Qualitative Study
31. Innovation in gynaecological cancer: highlighting global disparities
32. Cancer of the cervix uteri
33. Cervical cancer prevention: New opportunities for primary and secondary prevention in the 21st century
34. HIV and HPV as Fatal Partners
35. Control of Cancer of the Cervix in Low- and Middle-Income Countries
36. Cytological screening for cervical cancer prevention
37. HPV vaccine introduction and implementation in Low- and Middle-Income Countries
38. Clinical utility of reflex testing with cancer biomarkers to improve diagnostic accuracy of primary Human Papillomavirus screening
39. Rapid Rise in Detection of Human Papillomavirus (HPV) Infection Soon After Incident HIV Infection Among South African Women
40. Cervical Cancer
41. Prevention of Cervical Cancer
42. Recurrence of Symptomatic Bacterial Vaginosis 12 Months after Oral Metronidazole Therapy in HIV-Positive and -Negative Women
43. Nested Case-Control Study of Cervical Mucosal Lesions, Ectopy, and Incident HIV Infection Among Women in Cape Town, South Africa
44. Bacterial Vaginosis and Susceptibility to HIV Infection in South African Women: A Nested Case-Control Study
45. Reply to staging classification for cancer of the ovary and fallopian tube should include in situ carcinoma
46. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells
47. Intravaginal Practices, HIV and Other Sexually Transmitted Diseases Among South African Women
48. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa
49. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms
50. Screen-and-treat approaches for cervical cancer prevention in low-resource settings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.